Skip to main content
Asian Pacific Journal of Cancer Prevention : APJCP logoLink to Asian Pacific Journal of Cancer Prevention : APJCP
. 2017;18(2):541–548. doi: 10.22034/APJCP.2017.18.2.541

Diagnostic Value of Fine-Needle Aspiration Biopsies and Pathologic Methods for Benign and Malignant Breast Masses and Axillary Node Assessment

Mojtaba Ahmadinejad 1, Leila Hajimaghsoudi 1, Seyyed Mohsen Pouryaghobi 2, Izadmehr Ahmadinejad 3, Koorosh Ahmadi 4,*
PMCID: PMC5454756  PMID: 28345843

Abstract

Bacground:

The goal of this study was to evaluate the fine needle aspiration (FNA) preoperatively together with Touch Print, Crush Print, frozen section and pathologic methods to reach a diagnosis for patients with breast and axillary masses.

Methods:

This study was conducted on 107 patients, and included 111 samples of breast and 43 of axillary masses taken at surgery. Data on epidemiological and clinical features of the patients were collected using a questionnaire. The results of the methods of FNA, Touch Print, and Crush Print were compared with the results of pathology after operations.

Results:

Comparison between the diagnosis values of FNA with pathology for breast cancer showed sensitivity, sensitivity, positive predictive values, negative predictive values, positive mendacious percentages, and negative mendacious percentages of 80.4%, 98%, 97.3%, 87.6%, 2%, and 19.6%, respectively, and for metastatic axillary lymph nodes, 80%, 95.6%, 94.1%, 84.6%, 4.4%, and 20%. Comparison of diagnosis values of FNA with Touch Print and Crush Print for breast cancer gave values of 82.2%, 89%, 97.3%, 89%, 1.6%, and 17.8%, respectively, and for metastatic axillary lymph nodes 84.2%, 95.8%, 94.1%, 88.4%, 14.2%, and 15.8%.

Conclusion:

Use of these methods, compared with pathology, can decrease cost, time, and a need for a second surgery and related complications.

Keywords: Breast, axillary, mass, fine-needle aspiration, pathology

Introduction

Palpable breast mass is a common problem among female patients. The diagnostic delays of breast cancer occur due to the generally low index of suspicion. Breast and axillary masses are the most prevalent breast diseases among the women. In case of existence, analyzing them is necessary to reject their malignancy and the accuracy of diagnosis can be increased by a combination of preoperative tests. The valuable diagnostic methods for this case are Fine-Needle Aspiration (FNA), Touch Print, Crush Print, and pathology. Intraoperative evaluation consisted of touch imprint cytology (TIC), frozen section (FS) analysis, scrape cytology or combination of these methods with own advantages and disadvantages (Creager et al.,2004; Van de Vrande et al., 2009).

Fine-needle aspiration (FNAB) has shown to be as a critical component in the investigation of palpable breast masses and is highly accurate method for diagnosing breast lesions (Rubin et al., 1997; Boerner and Sneige, 1998). It is cheaper and is available within a shorter time. FNAB has been demonstrated to have some advantages over core-needle biopsy(CNB) in that it use a smaller needle and thus has a lower probability of causing hematoma and other rare complications, such as pneumothorax (Dowlatshahi et al., 1987; Evans et al., 1989). It is worth noting that the clinical use of FNAB has been questioned due to variability in performance known as an adjunct to open surgical biopsy that is increasingly being used in the evaluation of breast disease. CNB has been progressively replacing FNAB in this preoperative evaluation role and is a choice in the assessment of micro-calcifications without a correlated mass lesion. CNB may be used as an additional tool when FNAB is not available (Jackson and Reynolds, 1991; Bilous, 2010).

Many studies have 9 CNB to have superior diagnostic accuracy based on solely historical comparisons of CNB and FNA series (Shannon et al., 2001; Pijnappel et al., 2004; El-Sayed et al., 2008). Some studies indicated that CNB yield more conclusive diagnoses as compared to FNA in both malignant and benign lesions (Symmans et al., 1999; Garg et al., 2007; Barra Ade et al., 2008). Both Frozen Section (FS) and touch imprint cytology (TIC) are used to evaluate whether a lesion is malignant or not (Liu et al., 2002; Hentry-Tillman et al., 2002). Intra operative cytology (IC), including touch imprint (TI) and crash preparations (CP), has been applied for diagnosis of breast, thyroid, parathyroid, and salivary gland specimen (Paessler et al., 2001; Shidham et al., 2002).

TIC would allow immediate reporting with no additional intervention or risk to the patient other than the CNB itself. TIC has so far been applied in the diagnosis of screen detected, impalpable breast lesions or in a mixed case load (Sneige et al., 2000;Newman et al., 2001; Green et al., 2001; Kass et al., 2003; Carmichael et al., 2004)

In the present study, FNA preoperatively together with Touch Print, Crush Print, and frozen section intraoperatively are applied to reach a diagnosis for patients with a breast mass and the results of intraoperative Crush Print and Touch Print were compared with permanent pathology.

Materials and Methods

Ethical Committee

The study was carried out according to the principles of the Declaration of Helsinki. The study protocol was approved by the Ethics Committee of Tehran Heart Center, and informed written consent was obtained from all the patients.

Study population

This cross-sectional study was conducted on 107 patients, who had been referred to Shohada Ashayer Hospital of Khorramabad, between 2012 and 2013. The patients were suffering from breast and axillary masses that included 111 samples of breast masses and 43 samples of axillary masses. All confirmed patients with breast and axillary mass by using clinical examination, mammography, ultrasound and FNA and surgical candidates were included in the study.

Epidemiology and clinical characteristics

After taking the informed consents, the epidemiological and clinical features of the patients were collected by an anonymous questionnaire which completed by a trained assistant through interview. The questionnaire was included: demographic data such as age, sex, marital status, religion, location, age of marriage, as well as questions about a history of heart disease, history of smoking and alcohol consumption, OCP and history of breast and axillary lymph nodes diseases in the family (first and second degree relatives). The anatomical location of the masses was also determined according to the physical examination or mammography and ultrasonography.

FNA and pathology procudures

FNA was done preoperatively, and Touch Print and Crush Print were prepared intraoperatively and then were sent to the Pathology Ward.

In the second part of the questionnaire, Crush Print, Touch Print results were recorded. The results of pathology were also received (an average of 7 to 10 days) and then pathology of breast and axillary lymph nodes were registered in our study. The results of FNA, Touch Print, and Crush Print methods were compared with the results of pathology after operation. The diagnostic values including sensitivity, specificity, negative predictive value (NPV), positive predictive value (PPV), positive mendacious percentage, and negative mendacious percentage were estimated for the three methods.

Results

FNA findings of breast masses

The demographic characteristics of the patients with breast masses were showed in Table 1. The mean age of the patients with breast masses was 40.1 ± 13.7 year olds. The highest frequency of breast masses (49%) were seen in the age group of 49-30 years and the lowest frequency were belonged to the group of over 70 years old. (Table 1). The mean age of the patients with malignant tumors of the breast was 49.6 ± 11.7 years and the patients with benign breast lumps 32.8± 10.8 years old (P<0.001). Moreover, 77 % of patients with breast masses had married and educational degrees of the majority of them (39%) were high school and 74% of them have been settled in city. Our findings showed that 15.2% of patients had a history of breast disease in their first and second degree relatives. Moreover, 57% of breast lumps were not malignant, while 43% were diagnosed to be malignant, as well as 49% of breast lump was located in right breast. In terms of location of the mass, the most abundant involved quadrant was upper outer quadrant of the right breast (in the case of single mass; 25%) and lowest frequencies was belonged to upper inner quadrant of the right breast (2 %). In cases where the greater number of the masses was observed, the most involved quadrants were the upper outer quadrant of the left breast and central quadrant of the right breast (Table 2 and 3).

Table 1.

The Frequency Distribution Characteristics of Patients with Breast Masses by Age, Marital Status, Education Level and Location in Patients

Variable Frequency the relative abundance(N) (Percent) Cumulative Frequency
Age groups 25 25 25
49 49 74
23 23 97
3 3 100
Marital status Married 77 77 77
Single 21 21 98
Divorced 2 2 100
Illiterate 26 26 26
Education Advice and less 23 23 49
High school 39 39 88
Collegiate 12 12 100
Address City 74 74 74
Village 26 26 100

Table 2.

Frequency of Smoking and Alcohol and Hormonal Birth Control Pills and History of Breast Disease in First Degree Relatives or II Patients

Variable Frequency The relative abundance(N) (Percent) Cumulative Frequency
History of breast disease in first degree relatives or second Yes 15 15.2 (15.2)
No 84 (84.8) 100
History of smoking and alcohol Yes 1 1 1
No 99 99 100
History of ocp Yes 39 39 39
No 61 61 100

Table 3.

Distribution of the Anatomical Location of the Mass, Quadrant of Breast Masses and Mass Deployment in Patients

Variable Frequency The relative abundance(N) (Percent) Cumulative Frequency
Anatomical location of the mass Her right breast. 49 49 49
Left breast 44 44 93
Both breasts 7 7 100
The nature of mass Benign 57 57 57
Malignant 43 43 100
Foreign upper 25 25 25
Right breast. 16 16 41
Foreign upper left breast 2 2 43
Internal upper right breast. 12 12 55
Quadrant mass deployment Internal upper left breast 4 4 59
Foreign bottom right breast. 3 3 64
External lower left breast 4 4 66
Lower right internal mammary 6 6 72
Lower left internal mammary 14 14 86
Right Breast Center 7 7 93
Left Breast Center 1 1 94
Internal lower right breast and the left breast upper outer 2 2 96
Foreign bottom right breast and the left breast center 3 3 99
Foreign upper right and lower left internal mammary 1 1 100

Pathological findings of breast masses

Based on the pathological study, the most common benign lumps was fiber adenoma (61.4 %) and the lowest frequency was belonged to papilloma cyst and lipoma and (each one 1.7%), as well as the most common malignant neoplasms was seen to be ductal carcinoma (Table 4).

Table 4.

The Distribution of Mass Pathological Benign and Malignant Breast Lesions in Patients

Variable Frequency The relative abundance (N) (Percent) Cumulative Frequency
Pathological types of benign Fibroadenomas 35 61.4 (61.4)
fibrocystic 14 24.5 (85.9)
papilloma cyst 1 1.7 (87.6)
Mastitis 6 10.7 (98.3)
Pathological types of malignant neoplasms Lipoma 1 1.7 (100)
Ductal carcinoma 41 (93.1) (93.1)
Medullary carcinoma 2 (6.9) (100)

Our imaging findings of patients with breast masses demonstrated that, among the 69 patients with a sonography, 58% of cases showed the possibility of malignancy and out of 46 patients with mammography, 68.2 % of them had a cancer possibility, (Table 5).

Table 5.

Distribution of Breast Masses Imaging Findings in Patients

Variable Frequency The relative abundance(N) (Percent) Cumulative Frequency
Ultrasound The possibility of malignancy 40 58 58
The possibility of benign 29 42 100
Mammography The possibility of malignancy 30 (68.2) (68.2)
The possibility of benign 14 (31.8) 100

FNA and pathological findings of axillary masses

The mean age of patients with axillary mass was 48.1± 13.3 years, the youngest patient with axillary mass was 20 years old and the oldest 77 years old.

The mean age of patients with malignant tumors of the axillary gland was 52.2 ± 12.4 years old while it was 46.3± 14.3 in patients with benign axillary masses (P= 0.32).

The average age of marriage in patients with axillary mass was18.3± 4.3 years old and the youngest had 10 years old. In these patients, the most frequent axillary mass was observed in the age group of 59-40 years old (57.1%). In addition, 92.9 % of these patients had married and the majority of them (38.1%) were illiterate. It is worth noting that, 78.6 % of patients were living in cities and nine cases of them (21.4%) had family history of breast disease in the first and second degree relatives. one case of these patients (2.4%) had a history of smoking and 21 patients (50%) had a history of oral contraceptive tables (Table 6, 7, 8, 9).

Table 6.

Comparison of the Diagnostic value of FNA with Pathology in the Diagnosis of Malignant Breast Masses in Patients

Pathology +.Number (%) -.Number (%) Total.Number (%)
FNA
+.Number (%) (97.4) 37 (2.6) 1 (100) 38
-.Number (%) (12.3) 9 (87.7) 64 (100) 73
Total.Number (%) (41.4) 46 (58.6) 65 (100) 111

Type of test, chi-square; X2, 74.4; PV < 0.0001

Table 7.

Comparison of the Diagnostic Value of Touch Print with Pathology in the Diagnosis of Malignant Breast Tumors in Patients

Pathology +.Number (%) -.Number (%) Total.Number (%)
Touch Print
+.Number (%) (100) 45 (0) 0 (100) 45
-.Number (%) (1.5) 1 (98.5) 65 (100) 66
Total.Number (%) (41.4) 46 (58.5) 65 (100) 111

Statistical analysis, Fisher’s exact test; X2, 106.9; PV < 0.0001

Table 8.

Comparison of the Diagnostic Value of Crush Print with Pathology in the Diagnosis of Malignant Breast Masses in Patients

Pathology +/Number (%) -/Number (%) Total/Number (%)
Crush Print
+/Number (%) (100) 45 0(0) 0 (100) 45
-/Number (%) (1.5) 1 (98.5) 65 (100) 66
Total/Number (%) (41.4) 46 (58.5) 65 (100) 111

Statistical analysis, Fisher’s exact test; X2, 106.9; PV < 0.0001

Table 9.

Comparison of the Diagnostic Value of Touch Print with FNA in the Diagnosis of Malignant Breast Masses in Patients

Touch Print +/Number (%) -/Number (%) Total/Number (%)
FNA
+/Number (%) (97.4) 37 (2.6) 1 38(100)
-/Number (%) (11) 8 (89) 65 73(100)
Total/Number (%) (40.5) 45 (59.5) 66 111(100)

Statistical analysis, chi-square; X2= 106/9; PV < 0.0001

The imaging findings in patients with axillae mass was showed that among 11 patients with ultrasonography evaluation, 81.8 % had probability of malignancy while among 7 patients with mammography, 85.7% of patients showed probability of malignancy (Table 10 and 11).

Table 10.

Comparison of the Diagnostic Value of Crush Print with FNA in the Diagnosis of Malignant Breast Masses in Patients

Crush Print +/Number (%) -/Number (%) Total/Number (%)
FNA
+/Number (%) (100) 45 (0) 0 (100) 45
-/Number (%) (1.5) 1 (98.5) 65 (100) 66
Total/Number (%) (41.4) 46 (58.5) 65 (100) 111

Statistical analysis, Fisher’s exact test; X2, 106.9; PV < 0.0001

Table 11.

Summary Results of the Diagnostic Value of FNA, Crush Print, and Touch Print with Pathology in the Diagnosis of Malignant Masses in Patients with Breast and Axilla

Accreditation criteria tests Sensitivity Property + _ % False negative % False positive LR+
Breast Masses FNA 80.4% 98.0% 97.3% 87.6% 19.6% 2.0% 40.2
Touch Print 97.8% 100.0% 100.0% 98.4% 2.2% 0.0% -
Cruch Print 97.8% 100.0% 100.0% 98.4% 2.2% 0.0% -
Axillary Masses FNA 80.0% 95.6% 94.1% 84.6% 20.0% 4.4% 18.18
Touch Print 90.0% 95.6% 94.7% 91.6% 10.0% 4.4% 20.45
Cruch Print 90.0% 95.6% 94.7% 91.6% 10.0% 4.4% 20.45

Comparison of fine needle aspiration and pathology findings

Comparing the diagnosis values of Touch Print and Crush Print with pathology for breast cancer showed sensitivity of 97.8%, specificity of 100%, positive predictive value of 100%, negative predictive value of 98.4%, positive mendacious percentage of 0%, and negative mendacious percentage of 2.2%, and for metastatic axillary lymph nodes, sensitivity of 90%, specificity of 95.6%, positive predictive value of 94.7%, negative predictive value of 91.6%, positive mendacious percentage of 4.4%, and negative mendacious percentage of 10% were obtained. Comparison between the diagnosis values of FNA with pathology for breast cancer showed sensitivity, sensitivity, positive predictive value, negative predictive value, positive mendacious percentage, and negative mendacious percentage of 80.4%, 98%, 97.3%, 87.6%, 2%, and 19.6%, respectively, and for metastatic axillary lymph nodes, they were 80%, 95.6%, 94.1%, 84.6%, 4.4%, and 20%, respectively. Comparison between the diagnosis values of FNA with Touch Print and Crush Print for breast cancer reported sensitivity, specificity, positive predictive value, negative predictive value, positive mendacious percentage, and negative mendacious percentage to be 82.2%, 89%, 97.3%, 89%, 1.6%, and 17.8%, respectively, and for metastatic axillary lymph nodes they were 84.2%, 95.8%, 94.1%, 88.4%, 14.2%, and 15.8%, respectively (Table 11).

Discussion

Breast and axillary masses are the most prevalent breast diseases among the women. In case of existence, analyzing them is necessary to reject their malignancy and the accuracy of diagnosis can be increased by a combination of preoperative tests. In the present study, fine needle aspiration (FNA) preoperatively together with Touch Print, Crush Print, and frozen section intraoperatively was used for diagnosis of patients with a breast mass and the results of intraoperative Crush Print and Touch Print were compared with permanent pathology.

The mean age of the patients with breast masses was 40.1 ± 13.7 year olds. The highest frequency of breast masses (49%) were seen in the age group of 49-30 years and the lowest frequency were belonged to the group of over 70 years old. (Table 4). The mean age of the patients with malignant tumors of the breast was 49.6 ± 11.7 years and the patients with benign breast lumps 6.10±8.32 years old (P<0.001).

The mean age of patients with axillary mass was 48.1± 13.3 years, the youngest patient with axillary mass was 20 years old and the oldest 77 years old.

The mean age of patients with malignant tumors of the axillary gland was 52.2 ± 12.4 years old while it was 46.3± 14.3 in patients with benign axillary masses (P= 0.32). Hamidian Jahromi et al. was conducted a study on146 sentinel lymph nodes from 74 consecutive patients with invasive breast cancer. They reported that the average age of patients were 49±13.6 (Jahromi et al., 2009). The average age of diagnosis and surgery have been reported in other studies in Iran to be between 46 to 48 years old (Vahdaninia et al., 2003; Akbari et al., 2006; Bakhtiari A, Hah-Ahmadi, 2006). Previous studies had suggested that the age of breast cancer in Iran is lower than the western countries (Less than 10 years), (Mousavi et al., 2007). The mean age of the patients that has been studied by Carlo et al, at Texas was 56.7 years old. Moreover, Yang and colleagues in China, Anyanwa in Nigeria, Sarra et al. in Dakar, have been reported taht the mean age of the patients was less than or equal to 45 years (Anyanwu,2000;Carlo et al., 2005; Yang et al., 2005; Sarra et al., 2006). Although smoking and alcohol are as a risk factor in the occurrence of cancer. Our study show only one patient with breast lumps had a history of alcohol consumption and one patient with axillary mass had history of smoking. It seems that these results have achieved due to gender of patients and also conventional and legal restrictions.

Previous studies have indicated that estrogen levels in the blood of breast cancer patients from are higher as compared to healthy individuals. Although there is no consensus the association of OCP usage of childbearing age with breast cancer, but it seems that it has an estrogen-associated effect on breast cancer risk and consumption of OCP at a younger age, especially before age 20 have a greater effect on the risk of breast cancer (Akbari, 2010). In our study, 39% of patients with breast lumps had a history of OCP and 50 % of those with axillary mass had a history of OCP consumption. In the present study, it seems that this association is stronger as compared to previous studies. Alkuwari et al., (2008) reported that the overall sensitivity of axillary lymph node FNA in all the cases studied was 65% and the specificity was 100%. They stated that FNA of axillary lymph nodes is a sensitive and very specific method with which to detect metastasis in breast cancer patients. Martha et al., (2010) indicated that Of the 224 patients, 51 patients (23%) had a positive ultrasound-guided FNA result, which yields an overall sensitivity of 59% and specificity of 100%. Ultrasound-guided FNA of the axillary lymph nodes is most useful in the preoperative assessment of patients with large tumors (> 2 cm) or lymph nodes that appear abnormal. In our study, comparison between the diagnosis values of FNA with pathology for breast cancer showed sensitivity, sensitivity, positive predictive value, negative predictive value, positive mendacious percentage, and negative mendacious percentage of 80.4%, 98%, 97.3%, 87.6%, 2%, and 19.6%, respectively, and for metastatic axillary lymph nodes, they were 80%, 95.6%, 94.1%, 84.6%, 4.4%, and 20%, respectively. In our study, the specificity of FNA was higher than study of Alkuwari et al. but both sensitivity are approximately equal. Furthermore, for metastatic axillary lymph nodes, they were 80%, 95.6%, 94.1%, 84.6%, 4.4%, and 20%, respectively, which compared with previous studies are more sensitive (Mdels et al.,2008;Martha et al.,2010).

Kuenen-Boumeester et al.(Kuenen-Boumeester et al.,2003) recommended that ultrasound-guided FNA be included in the preoperative staging of all primary breast cancer patients. Koelliker et al., (2008) found ultrasound-guided FNA to be beneficial in a selected population of patients with T1 tumors, including one with normal-appearing lymph nodes.

Chen et al, (2010) found that multiple cross-sectional TIC has a sensitivity, specificity, and overall accuracy rate of 92.0, 99.0, and 97.5%, respectively, on a per-patient basis, and it is superior to the standard imprint preparation protocol. It has been found that the sensitivity of TIC has varied widely from 34% to 96%. Nevertheless, these data cannot be compared in terms of sensitivity and accuracy due to patient differences, variation in how the TIC protocol was implemented, final histopathological evaluation, and cytologist experience. Interpretation of imprints is operator dependent, as reflected in the wide range of success in previous studies, with sensitivities ranging from 33.3% to 100 % (Chicken et al., 2006).

Chicken et al., (2006) used touch imprint cytology for the diagnosis of sentinel lymph node metastases in breast cancer. They concluded that TIC detected metastases with a sensitivity of 81.1%and a specificity of 100% and TIC is feasible and enables the rapid diagnosis of SLN metastases with an acceptable accuracy for clinical use in ductal carcinoma of the breast.

In the present study, comparison between the diagnosis values of FNA with Touch Print and Crush Print for breast cancer reported sensitivity, specificity, positive predictive value, negative predictive value, positive mendacious percentage, and negative mendacious percentage to be 82.2%, 89%, 97.3%, 89%, 1.6%, and 17.8%, respectively, and for metastatic axillary lymph nodes they were 84.2%, 95.8%, 94.1%, 88.4%, 14.2%, and 15.8%, respectively. In addition, in terms of Touch Print and Crush Print, our study had high sensitivity, specificity and positive predictive value for the diagnosis of breast cancer. Furthermore, the sensitivity of the Touch Print, Crush Print for evaluation of the axillary mass were higher than previously mentioned studies (Perez-Sanchez et al.,2010; Khanna et al.,2011), indicating the high diagnostic value of Touch Print, and Crush Print.

In conclusion, due to the high sensitivity and specificity and positive predictive value of Touch Print, Crush Print as compared to the frozen section for breast cancer and the high sensitivity of these methods in comparison with the Frozen section for metastatic axillary masses, these methods can be very useful for diagnosis of breast cancer and metastatic axillary lumps.

By using Touch Print and Crush Print, the type of tissue can be detected during the operation in few minutes. Furthermore, due to the high specificity of these methods, are recommended when the there is no possibility of using Frozen section. Thus, these methods can save the patient from cost and time, reoperation, and complications.

References

  1. Akbari A. Parity and breast feeding are preventive Measures for breast cancer in Iranian women. J Breast Cancer. 2010;52:93–7. [Google Scholar]
  2. Akbari ME, Mirzaei HR, Soori H. 5 year survival of breast cancer in Shohada - e - Tajrish and Jorjani hospital. Hakim. 2006;9:39–44. [Google Scholar]
  3. Alkuwari E, Auger M. Accuracy of fine-needle aspiration cytology of axillary lymph nodes in breast cancer patients: a study of 115 cases with cytologic-histologic correlation. Cancer. 2008;114:89–93. doi: 10.1002/cncr.23344. [DOI] [PubMed] [Google Scholar]
  4. Anyanwu SN. Survival following treatment of primary breast cancer in eastern Nigeria. East Afr Med J. 2000;77:539–43. [PubMed] [Google Scholar]
  5. Bakhtiari A, Hah-Ahmadi M. 5 years assessment of breast cancer at Rajaii hospital, Baboolsar (1991-1996) Iran J Obstet Gynecol Infertil. 2006;9:47–52. [Google Scholar]
  6. Barra Ade A, Gobbi H, de L, Rezende CA. A comparision of aspiration cytology and core needle biopsy according to tumor size of suspicious breast lesions. Diagn Cytopathol. 2008;36:26–31. doi: 10.1002/dc.20748. [DOI] [PubMed] [Google Scholar]
  7. Bilous M. Breast core needle biopsy: issues and controversies. Mod Pathol. 2010;23:36–45. doi: 10.1038/modpathol.2010.34. [DOI] [PubMed] [Google Scholar]
  8. Boerner S, Sneige N. Specimen adequacy and falsenegative diagnosis rate in fine-needle aspirates of palpable breast masses. Cancer. 1998;84:344–48. [PubMed] [Google Scholar]
  9. Carlo JT, Grant MD, Knox SM, Jones RC, Hamilton CS. Survival analysis following sentinel lymph node biopsy: a valid ation trial demonstrating its accuracy in staging early breast cancer. BUM C Proceeding. 2005;18:103–7. doi: 10.1080/08998280.2005.11928044. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Carmichael AR, Berresford A, Sami A, Boparai R. Imprint cytology of needle core-biopsy specimens of breast lesion: is it best of both worlds? Breast. 2004;13:232–4. doi: 10.1016/j.breast.2003.08.008. [DOI] [PubMed] [Google Scholar]
  11. Chen JJ, Yang BL, Zhang JX, et al. The evaluation and optimization of intraoperative touch imprint cytology for sentinel lymph nodes in early-stage breast cancer in China. World J Surg. 2010;34:2325–32. doi: 10.1007/s00268-010-0684-0. [DOI] [PubMed] [Google Scholar]
  12. Chicken DW, Kocjan G, Falzon M, et al. Intraoperative touch imprint cytology for the diagnosis of sentinel lymph node metastases in breast cancer. Br J Surg. 2006;93:572–6. doi: 10.1002/bjs.5289. [DOI] [PubMed] [Google Scholar]
  13. Creager AJ, Geisinger KR, Perrier ND, et al. Intraoperative imprint cytologic evaluation of sentinel lymph nodes for lobular carcinoma of the breast. Ann Surg. 2004;239:61–6. doi: 10.1097/01.sla.0000103072.34708.e3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Dowlatshahi K, Jokich PM, Schmidt R, Bibbo M, Dawson PJ. Cytologic diagnosis of occult breast lesions using stereotactic needle aspiration: a preliminary report. Arch Surg. 1987;122:1343–46. doi: 10.1001/archsurg.1987.01400230131023. [DOI] [PubMed] [Google Scholar]
  15. El-Sayed ME, Rakha EA, Reed J, et al. Audit of performance of needle core biopsy diagnoses of screen detected breast lesions. Eur J Cancer. 2008;44:2580–6. doi: 10.1016/j.ejca.2008.05.024. [DOI] [PubMed] [Google Scholar]
  16. Evans WP, Cade SH. Needle localization and fine-needle aspiration biopsy of nonpalpable breast lesions with use of standard and stereotactic equipment. Radiology. 1989;173:53–6. doi: 10.1148/radiology.173.1.2675189. [DOI] [PubMed] [Google Scholar]
  17. Garg S, Mohan H, Bal A, Attri AK, Kochhar S. A comparative analysis of core needle biopsy and fine-needle aspiration cytology in the evaluation of palpable and mammographically detected suspicious breast lesions. Diagn Cytopathol. 2007;35:681–9. doi: 10.1002/dc.20721. [DOI] [PubMed] [Google Scholar]
  18. Green RS, Mathew S. The contribution of cytologic imprints of stereotactically guided core needle biopsies of the breast in the management of patients with mammographic abnormalities. Breast J. 2001;7:214–8. doi: 10.1046/j.1524-4741.2001.99070.x. [DOI] [PubMed] [Google Scholar]
  19. Hentry-Tillman RS, Korourian S, Rubio IT, et al. Intraoperative touch prepation for sentinel lumph node biopsy: a 4-year experience. Ann Surg Oncol. 2002;9:321–3. doi: 10.1007/BF02573867. [DOI] [PubMed] [Google Scholar]
  20. Jackson VP, Reynolds HE. Stereotactic needle-core biopsy and fine-needle aspiration cytologic eva-luation of nonpalpable breast lesions. Radiology. 1991;181:633–634. doi: 10.1148/radiology.181.3.1947072. [DOI] [PubMed] [Google Scholar]
  21. Jahromi AH, Narayanan S, MacNeill F, et al. Testing the feasibility of intra-operative sentinel lymph node touch imprint cytology. Ann R Coll Surg Engl. 2009;91:336–39. doi: 10.1308/003588409X391758a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Kass R, Henry-Tillman RS, Nurko J. Touch preparation of breast core needle specimens is a new method for sameday diagnosis. Am J Surg. 2003;186:737. doi: 10.1016/j.amjsurg.2003.08.026. [DOI] [PubMed] [Google Scholar]
  23. Khanna R, Bhadani S, khanna S, pandey M, kumar M. Touch imprint cytology evaluation of sentinel lymph node in breast cancer. World J Surg. 2011;35:1254–9. doi: 10.1007/s00268-011-1094-7. [DOI] [PubMed] [Google Scholar]
  24. Koelliker SL, Chung MA, Mainiero MB, Steinhoff MM, Cady B. Axillary lymph nodes: USguided fine-needle aspiration for initial staging of breast cancer-correlation with primary tumor size. Radiology. 2008;246:81–9. doi: 10.1148/radiol.2463061463. [DOI] [PubMed] [Google Scholar]
  25. Kuenen-Boumeester V, Menke-Pluymers M, de Kanter AY, et al. Ultrasound-guided fine needle aspiration cytology of axillary lymph nodes in breast cancer patients: a preoperative staging procedure. Eur J Cancer. 2003;39:170–74. doi: 10.1016/s0959-8049(02)00501-4. [DOI] [PubMed] [Google Scholar]
  26. Liu Y, Silverman JF, Sturgis CD, et al. Utilityofintraoperative consultation touch preparations. Diagn Cytopathol. 2002;26:329–33. doi: 10.1002/dc.10102. [DOI] [PubMed] [Google Scholar]
  27. Martha B, Christina M, Susan L, Theresa A, Maureen A. Axillary ulthrasound and FNA in the preoperative evaluation of the breast cancer patient. An algorithm based on tumor size and lymph node appearance. Cancer. 2010;89:1310–13. [Google Scholar]
  28. Mdels RF, Santillan Arreygue L, Olvera Hernandez PC, Morales sanchez MA, Ramirez Mendiola VL. Frequency of risk factors in Breast cancer. Ginecol obstet Mex. 2005;76:667–72. [PubMed] [Google Scholar]
  29. Mousavi S, Montazeri A, Mohagheghi M, et al. breast cancer in iran: an epidemiological review. Breast J. 2005;13:383–91. doi: 10.1111/j.1524-4741.2007.00446.x. [DOI] [PubMed] [Google Scholar]
  30. Newman MR, Frost FA, Sterrett GF, et al. Diagnosis of breast microcalcifications: a comparison of stereotactic FNA and core imprint cytology as adjuncts to core biopsy. Pathology. 2001;33:449–53. doi: 10.1080/00313020127148. [DOI] [PubMed] [Google Scholar]
  31. Paessler M, LiVolsi VA, Baloch ZW. Role of ultrafast Papanicolaou-stained scrape preparations as an adjunct to frozen sections in the surgical management of thyroid lesions. Endocr Pract. 2001;7:89–94. doi: 10.4158/EP.7.2.89. [DOI] [PubMed] [Google Scholar]
  32. Perez-Sanchez VM, Vela-Chavez TA, Villarreal-Colin P. Intraoperative touch imprint cytology of sentinel lymph nodes in breast cancer: experience at a tertiary care center in Mexico. Med Oncol. 2010;27:233–6. doi: 10.1007/s12032-009-9197-9. [DOI] [PubMed] [Google Scholar]
  33. Pijnappel RM, Van den Donk M, Holland R. Diagnostic accuracy for different strategies of image-guided breast intervention in cases of nonpalpable breast lesions. Br J Cancer. 2004;90:595–600. doi: 10.1038/sj.bjc.6601559. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Rubin M, Horiuchi K, Joy N. Use of fine needle aspiration for solid breast lesions is accurate and costeffective. Am J Surg. 1997;174:694–98. doi: 10.1016/s0002-9610(97)00192-x. [DOI] [PubMed] [Google Scholar]
  35. Sarra B, Ogougbemy M, Dotou C, Lopy J. Epidemiologieal therapeutic and prognostic aspects of breast cancer: about 473 cases collected in hospital principle de Dakar. Dakar Med. 2006;51:92–6. [PubMed] [Google Scholar]
  36. Shannon J, Douglas-Jones AG, Dallimore NS. Conversion to core biopsy in preoperative diagnosis of breast lesions: is it justified by results? J Clin Pathol. 2001;54:762–5. doi: 10.1136/jcp.54.10.762. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Shidham VB, Asma Z, Rao RN, et al. Intraoperative cytology increases the diagnostic accuracy of frozen sections for the confirmation of various tissues in the parathyroid region. Am J Clin Pathol. 2002;118:895–902. doi: 10.1309/N46X-JW4D-DYXF-DB4Y. [DOI] [PubMed] [Google Scholar]
  38. Sneige N, Tulbah A. Accuracy of cytologic diagnoses made from touch imprints of image-guided needle biopsy specimens of nonpalpable breast abnormalities. Diagn Cytopathol. 2000;23:29–34. doi: 10.1002/1097-0339(200007)23:1<29::AID-DC7>3.0.CO;2-8. [DOI] [PubMed] [Google Scholar]
  39. Symmans WF, Weg N, Gross J. A prospective comparison of stereotaxic fine-needle aspiration versus stereotaxic core needle biopsy for the diagnosis of mammographic abnormalities. Cancer. 1999;85:1119–32. [PubMed] [Google Scholar]
  40. Vahdaninia MS, Harirchi AM, Montazeri A. Five –year survival in Iranian breast cancer patients: A prospective study. Payesh. 2003;2:141–48. [Google Scholar]
  41. Van de Vrande S, Meijer J, Rijnders A, Klinkenbijl JH. The value of intraoperative frozen section examination of sentinel lymph nodes in breast cancer. Eur J Surg Oncol. 2009;35:276–80. doi: 10.1016/j.ejso.2008.07.016. [DOI] [PubMed] [Google Scholar]
  42. Yang MT, Rong TH, Huang ZF, et al. Clinical analysis of resectable breast cancer: a report of 6263 cases. Ai Zheng. 2005;24:327–31. [PubMed] [Google Scholar]

Articles from Asian Pacific Journal of Cancer Prevention : APJCP are provided here courtesy of West Asia Organization for Cancer Prevention

RESOURCES